121 related articles for article (PubMed ID: 3545411)
1. Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide.
Bryan LE; Schollaardt T; Pak CY; Kim CJ; Yoon JW
Can J Microbiol; 1986 Dec; 32(12):967-9. PubMed ID: 3545411
[TBL] [Abstract][Full Text] [Related]
2. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
3. Antipili antibody affords protection against experimental ascending pyelonephritis.
Silverblatt FJ; Cohen LS
J Clin Invest; 1979 Jul; 64(1):333-6. PubMed ID: 376560
[TBL] [Abstract][Full Text] [Related]
4. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
Brooks SJ; Lyons JM; Braude AI
J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
[TBL] [Abstract][Full Text] [Related]
5. P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.
Roberts JA; Kaack MB; Baskin G; Korhonen TK; Svenson SB; Winberg J
Pediatr Nephrol; 1989 Oct; 3(4):391-6. PubMed ID: 2577147
[TBL] [Abstract][Full Text] [Related]
6. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B; Larsson P; Olling S
Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
[TBL] [Abstract][Full Text] [Related]
7. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
Brooks SJ; Lyons JM; Braude AI
Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
[TBL] [Abstract][Full Text] [Related]
8. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
Larsson P; Kaijser B; Baltzer IM; Olling S
Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
[TBL] [Abstract][Full Text] [Related]
11. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
[TBL] [Abstract][Full Text] [Related]
13. Pyelonephritis. XIV. Effect of immunization on experimental Escherichia coli pyelonephritis.
Montgomerie JZ; Kalmanson GM; Hubert EG; Guze LB
Infect Immun; 1972 Sep; 6(3):330-4. PubMed ID: 4564890
[TBL] [Abstract][Full Text] [Related]
14. Prevention of pyelonephritis by immunization with P-fimbriae.
Roberts JA; Hardaway K; Kaack B; Fussell EN; Baskin G
J Urol; 1984 Mar; 131(3):602-7. PubMed ID: 6199527
[TBL] [Abstract][Full Text] [Related]
15. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
Pecha B; Low D; O'Hanley P
J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
[TBL] [Abstract][Full Text] [Related]
16. Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.
Roberts JA; Kaack MB; Baskin G; Svenson SB
Infect Immun; 1993 Dec; 61(12):5214-8. PubMed ID: 8225595
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunization with ethanol-soluble enterobacterial common antigen on in vivo bacterial clearance and hematogenous pyelonephritis.
Frentz G; Domingue G
Proc Soc Exp Biol Med; 1973 Jan; 142(1):246-52. PubMed ID: 4566760
[No Abstract] [Full Text] [Related]
18. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
19. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of immunization in experimental E. coli pyelonephritis.
Spencer AG; Fairhead A
Clin Sci; 1971 Aug; 41(2):4P-5P. PubMed ID: 4935417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
